| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.27B | +5.7% |
| Cost of Revenue | $1.09B | +6.0% |
| Gross Profit | $1.18B | +5.4% |
| R&D Expense | $56.4M | +1.9% |
| SG&A Expense | $833.4M | +4.8% |
| Operating Income | $281.5M | +8.4% |
| Pre-tax Income | $259.4M | +4.7% |
| Income Tax | $54.4M | -14.5% |
| Net Income | $199.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $216.7M | +24.2% |
| Inventory | $674.7M | +63.2% |
| Current Assets | $1.06B | +9.3% |
| Total Assets | $2.19B | +9.4% |
| Current Liabilities | $548.6M | +13.6% |
| Long-term Debt | $526.3M | +67.1% |
| Total Liabilities | $1.21B | +31.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.8M | -121.6% |
| Capital Expenditures | $61.4M | +63.2% |
| Investing Cash Flow | -$140.2M | -273.0% |
| Financing Cash Flow | -$8.6M | +93.9% |
| Free Cash Flow | -$129.2M | -146.7% |
| +11.4% |
| EPS (Basic) | $2.77 | +15.4% |
| EPS (Diluted) | $2.75 | +15.5% |
| Stockholders' Equity |
| $939.1M |
| -10.0% |